Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Telehealth Prescribing topic
No spam. Unsubscribe anytime.
Federal jury convicts digital-health founder as commentators warn telehealth was used to push stimulants
Summary
A media segment reports a federal jury convicted Ruthie He and a clinical partner for allegedly using an online telehealth platform to distribute more than 40,000,000 stimulant pills with limited clinical oversight; speakers warned the case shows risks when growth-driven tech models enter medicine.
A federal jury has convicted Ruthie He, the founder of a digital health startup, and her clinical partner on charges described in the segment as relating to the large-scale distribution of stimulant medications through an online telehealth system. Commentator (Speaker 1) opened the segment by calling the operation “drug dealing rebranded as telehealth.”
Reporter (Speaker 2) said prosecutors presented evidence that the online system pushed more than 40,000,000 pills (referred to in the transcript as “Avadero”) with “very little real medical oversight.” The reporter added that He had strong technical credentials—trained at Carnegie Mellon and Peking University and with product roles at Facebook and Tencent—and that those skills were used to build a platform focused on growth and retention rather than patient care: “She knew exactly how to build platforms that scale, influence behavior, and drive engagement,” the Reporter said.
A separate voice on the recording (Witness, Speaker 3), describing personal experience with the site, said the patient-facing interface was minimal—“the web page came up... and it was, like, 3 buttons”—and called the platform “a game changer” for meeting perceived ADHD needs. The Reporter and Commentator relayed prosecutors’ claims that brief online evaluations, automated refills and pressure to prescribe allowed prescriptions to continue in some cases even as patients showed serious mental-health complications.
The segment also reported that, as scrutiny increased, operations were allegedly shifted overseas (including to China) and some communications moved to encrypted or disappearing channels. The Reporter characterized those changes as attempts to evade oversight rather than increase transparency.
Medical risk was a central theme of the discussion: the Reporter cautioned that stimulants such as Adderall “can be effective when prescribed responsibly,” but warned that without proper diagnosis and follow-up they can lead to addiction, anxiety, psychosis and even overdose.
The Commentator closed by framing the case as a wider problem when technology growth tactics intersect with controlled substances, saying that treating medicine like a tech product makes “patients become users, and prescriptions become transactions.” The transcript spells the founder’s name both as “Ruthie He” and (in one segment) “Ruthea He”; this article follows the initial reference in the recording as “Ruthie He.”
The segment did not specify the formal charges, the date of conviction, or any sentencing date; those details were not provided in the transcript.
